Stock Taper
EXCHANGE TRADED FUND

ASD

Defiance Autism Impact ETF
$28.26 ▼ 0.83%
−$0.24 TODAY

FUND FACTS

Manager Defiance
Assets $1.41M
Expense ratio 0.79%
Inception Jun 1, 2026
Asset class Equity
Holdings 22
Volume 37
Avg volume 635

ABOUT THIS FUND

It operates as an exchange-traded investment fund.

PRICE

$28.26 ▼ DOWN 0.83% (−$0.24)
$28.20$28.24$28.28$28.329:30 AM10:13 AM10:56 AM11:38 AM12:21 PM1:04 PM1:47 PM28.26

HOLDINGS

TOP 20 OF 22 · 54.48% OF THE FUND
RANK STOCK WEIGHT SHARES VALUE
01 DFTX Definium Therapeutics, Inc. 4.36% 1.37K $61.53K
03 ACAD ACADIA Pharmaceuticals Inc. 3.23% 1.54K $45.55K
04 RGEN Repligen Corporation 3.19% 248 $44.92K
05 AVXL Anavex Life Sciences Corp. 3.04% 13.22K $42.82K
08 ABBV AbbVie Inc. 2.74% 146 $38.68K
09 JNJ Johnson & Johnson 2.65% 138 $37.29K
13 PFE Pfizer Inc. 2.51% 1.26K $35.42K
14 LLY Eli Lilly and Company 2.49% 28 $35.15K
16 BWAY BrainsWay Ltd. 2.35% 2.25K $33.16K
17 GHC Graham Holdings Company 2.32% 28 $32.67K

SECTOR HOLDINGS

TECHNOLOGY IS 1.00% OF THE FUND

BY REGION

UNITED STATES IS 55.33% OF THE FUND
United States 55.33%
Japan 10.58%
Switzerland 5.19%
United Kingdom 4.87%
Israel 4.87%
Australia 4.06%
South Africa 2.73%
Sweden 2.70%
Ireland 2.53%
Other 2.52%
France 2.46%
Denmark 2.17%